Antarka
7 known investors
Find your way into Antarka
Sign up to see every warm intro you have to Antarka
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Antarka team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Antarka develops a skin-permeable enzyme derived from Antarctic organisms that repairs UV-induced DNA damage, offered as a high-purity active ingredient for cosmetic brands to formulate into anti-aging creams, sunscreens, and repair serums. The company operates in the biotech and dermocosmetics space, supplying formulators rather than selling finished consumer products directly.
Founders & leadership

Investors · 7
How we know: AIR Capital's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · sosv.com · Not right? Tell us
How we know: Vox Capital's portfolio page · Not right? Tell us
How we know: Zentynel Frontier Investments's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Antarka do?
- Antarka develops a skin-permeable enzyme derived from Antarctic organisms that repairs UV-induced DNA damage, offered as a high-purity active ingredient for cosmetic brands to formulate into anti-aging creams, sunscreens, and repair serums. The company operates in the biotech and dermocosmetics space, supplying formulators rather than selling finished consumer products directly.
- Who founded Antarka?
- Antarka was founded by Betania Martínez, Juan Jose Marizcurrena, Celica Cagide.
- Who are Antarka's investors?
- Antarka's investors include AIR Capital, GRIDX, GS Futures, SOSV, Vox Capital, Zentynel Frontier Investments, IndieBio.







